About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Clrn1tm1.1Ugpa
targeted mutation 1.1, Unite de Genetique et Physiologie de l'Audition, Institut Pasteur
MGI:6099051
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Clrn1tm1.1Ugpa/Clrn1tm1.1Ugpa
Myo15atm1.1(cre)Ugds/Myo15a+
involves: 129S1/SvImJ * C57BL/6N MGI:6467338


Genotype
MGI:6467338
cn1
Allelic
Composition
Clrn1tm1.1Ugpa/Clrn1tm1.1Ugpa
Myo15atm1.1(cre)Ugds/Myo15a+
Genetic
Background
involves: 129S1/SvImJ * C57BL/6N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Clrn1tm1.1Ugpa mutation (0 available); any Clrn1 mutation (16 available)
Myo15atm1.1(cre)Ugds mutation (0 available); any Myo15a mutation (136 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hearing/vestibular/ear
• at >P30, the stereocilia of the short row are heterogeneous in length with some missing entirely in IHCs
• stereocilia progressively regress until hair bundles degenerate completely by P120
• intracochlear AAV2/8-mediated delivery of clarin-1 results in normal hair bundles at P120; however, despite the persistence of V-shaped bundles, stereocilia in the short and middle rows are heterogeneous in length with many found to be missing
• at >P30, the stereocilia of the short row are heterogeneous in length with some missing entirely in OHCs
• stereocilia progressively regress until hair bundles degenerate completely by P120
• intracochlear AAV2/8-mediated delivery of clarin-1 results in normal hair bundles at P120; however, despite the persistence of V-shaped bundles, stereocilia in the short and middle rows are heterogeneous in length with many found to be missing
• at P28, TEM analysis revealed enlarged postsynaptic afferent terminals relative to control mice
• at P20, the postsynaptic GluA2/3-immunoreactive domain is abnormally expanded in the nerve terminals below the IHCs
• IHC stereociliary bundles degenerate completely by P120
• OHC stereociliary bundles degenerate completely by P120
• at P18, the Ca2+ current density in IHCs is almost twice that in control mice
• analysis of the voltage-dependent activation of Ca2+ currents revealed a negative shift of 7 mV at P18-P21 and a significantly less steep activation curve at P18; the negative shift is first noted at P9 prior to any significant changes in current amplitude and density and increases thereafter
• at >P9, the kinetics of Ca2+ current activation at negative membrane potentials are slower than in control mice; moreover, time-dependent inactivation of IHC Ca2+ currents is greater than in control mice at P13 and P18
• at P15-P20, ABR thresholds are 20-40 dB higher than those in control mice at all frequencies tested
• by P30-P60, ABR thresholds reach an SPL of 75-100 dB across the 5- to 40-kHz frequency spectrum
• intracochlear AAV2/8-mediated delivery of clarin-1 leads to a near complete rescue of hearing at all frequencies tested with hearing preserved up to P60
• at P15-P20, cochlear nerve compound action potential (CAP) wave I latencies recorded in response to loud sound stimuli (SPL of 95 dB) are 30% longer while CAP amplitudes are 75% smaller than in control mice
• at P20, electrically evoked brainstem response (EEBR) waves recorded in the cochleae after direct stimulation of primary auditory neurons are of smaller amplitude than those in control mice and the peaks of waves II (EII) and III (EIII) are significantly delayed
• DPOAE thresholds are normal up to P20 but progressively increase to reach an SPL 20-30 dB above that of control mice by P44
• mice exhibit profound deafness at P60
• mice exhibit progressive hearing loss starting as early as P15 and reaching profound deafness at P60

nervous system
• Ca2+ efficiency for IHC exocytosis is normal at P9 but significantly lower than that in control mice at P13
• following intracellular Ca2+ uncaging by UV flash photolysis, P14 IHCs show lower rates of exocytosis (dCm/dt) and lower exocytosis maximum amplitudes than control IHCs
• at >P30, the stereocilia of the short row are heterogeneous in length with some missing entirely in IHCs
• stereocilia progressively regress until hair bundles degenerate completely by P120
• intracochlear AAV2/8-mediated delivery of clarin-1 results in normal hair bundles at P120; however, despite the persistence of V-shaped bundles, stereocilia in the short and middle rows are heterogeneous in length with many found to be missing
• at >P30, the stereocilia of the short row are heterogeneous in length with some missing entirely in OHCs
• stereocilia progressively regress until hair bundles degenerate completely by P120
• intracochlear AAV2/8-mediated delivery of clarin-1 results in normal hair bundles at P120; however, despite the persistence of V-shaped bundles, stereocilia in the short and middle rows are heterogeneous in length with many found to be missing
• at P28, TEM analysis revealed enlarged postsynaptic afferent terminals relative to control mice
• at P20, the postsynaptic GluA2/3-immunoreactive domain is abnormally expanded in the nerve terminals below the IHCs
• IHC stereociliary bundles degenerate completely by P120
• OHC stereociliary bundles degenerate completely by P120
• at P18, the Ca2+ current density in IHCs is almost twice that in control mice
• analysis of the voltage-dependent activation of Ca2+ currents revealed a negative shift of 7 mV at P18-P21 and a significantly less steep activation curve at P18; the negative shift is first noted at P9 prior to any significant changes in current amplitude and density and increases thereafter
• at >P9, the kinetics of Ca2+ current activation at negative membrane potentials are slower than in control mice; moreover, time-dependent inactivation of IHC Ca2+ currents is greater than in control mice at P13 and P18
• at P15-P20, cochlear nerve compound action potential (CAP) wave I latencies recorded in response to loud sound stimuli (SPL of 95 dB) are 30% longer while CAP amplitudes are 75% smaller than in control mice
• at P20, electrically evoked brainstem response (EEBR) waves recorded in the cochleae after direct stimulation of primary auditory neurons are of smaller amplitude than those in control mice and the peaks of waves II (EII) and III (EIII) are significantly delayed
• mice exhibit and IHC synaptopathy characterized by a much weaker downregulation of Ca2+ currents than normally observed at the onset of hearing; a hyperpolarized voltage-activation curve and an extended calcium-dependent inactivation of Ca2+ currents; and an intrinsic defect of the exocytotic machinery
• the rate of colocalization for CaV1.3- and ribeye-immunoreactive areas is normal at P9, but significantly lower than that in control IHCs at P13 and P21, suggesting a loose spatial coupling between Ca2+ channels and the synaptic machinery
• at P13, the F-actin cortical network is disrupted at the IHC ribbon synapse
• however, IHCs exhibit normal frequencies of round (immature) and droplet-shaped (mature) synaptic ribbons at P15 and P28
• cochlear immunostaining with Neurofilament 200 (NF200) revealed a significant loss of auditory nerve fibers at P25

cellular
• Ca2+ efficiency for IHC exocytosis is normal at P9 but significantly lower than that in control mice at P13
• following intracellular Ca2+ uncaging by UV flash photolysis, P14 IHCs show lower rates of exocytosis (dCm/dt) and lower exocytosis maximum amplitudes than control IHCs

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
Usher syndrome type 3A DOID:0110841 OMIM:276902
J:265318





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/23/2024
MGI 6.23
The Jackson Laboratory